Genentech has recalled approximately 14,000 units of Evrysdi (risdiplam) for oral solution because a fit issue between the bottle adapter and the bottleneck can cause the bottles to leak. The recalled product is an amber-colored 100 mL bottle identified by the NDC number 20242-175-07, and it was sold through select specialty pharmacies nationwide starting in August 2020. If your bottle is leaking, you should contact Genentech for a free replacement as described in the Your Remedy Options section.
The leak poses a risk of drug exposure if the liquid contacts the skin or eyes; additionally, the product fails to meet mandatory child-resistant packaging requirements under the Poison Prevention Packaging Act. Genentech has received 26 reports of leaking bottles, though no injuries have been reported.
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
Recalled prescription drug Evrysdi
Recalled prescription drug with press-in bottle adapter
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response